Frequently asked questions


In this section we will try to answer the most frequent questions that our clients send us. There is certainly a lot of information to which we must respond. If you cannot find it here, you can send us your question to

Plants have been engaged in an evolutionary battle since the beginning of time. They have developed many compounds that all have a unique pharmacology. Animals living around those plants have evolved to function best in an environment that has certain terpenes always present.

Cannabis and people have co-evolved in a similar way, with the best terpene profiles being selected each harvest, to be planted the next year.

This could explain why the cannabis plant has such a comprehensive list of compounds that are of interest to human health.

The answer is yes. There is a Royal Decree 1729/1999 which stipulates that the concentration of THC (Tetrahydrocannabinol) in products must be less than 0.2%. But our products are 0% THC so using CBD products is totally safe and legal.

CBD is a non-psychotropic cannabinoid that does not alter the cognitive state of its users, making it a completely legal product available in most of the countries that make up the European Union.

Our products don’t contain THC or psychoactive principles, so it does not entail any harmful repercussions to our body. Different studies point out that it helps mitigate the effects of some diseases such as asthma, stress, diabetes, depression.

Currently there are many centers and establishments where you can buy CBD products.

In our CBD Nuuyu Shop , you will see and buy all the offer that Nuuyu currently has available.

Subscribe for



CIF: B01807692
Phone: +34 689 14 54 13
Email: info@nuuyu.com
Paseo de Gracia, 118 – Principal
08008, Barcelona


We do not claim CBD treats any medical conditions, any piece of content is about the properties of the individual plant terpenes, this agreement is to be governed by Spanish law. In Annex II of Regulation (EC) 1223/2009 on cosmetic products, hemp seeds and leaves are excluded
from the classification as narcotic drugs.

The European Commission states that: “Cannabidiol is not included as such in the Convention on Narcotic Drugs of 1961. Therefore, cannabidiol is considered outside the scope of Annex II, of Regulation (EC) 1223/2009 at entry 306”.

Currently in the European Union the use of cannabidiol is allowed as long as * it does not come from parts of the plant that are considered narcotic drugs *. Thus, the use of cannabidiol obtained from seeds and leaves is currently allowed on cosmetic products.